机译:Camrelizumab: an investigational agent for hepatocellular carcinoma
Zhongshan Hosp,Fudan Univ;
Camrelizumab; immune checkpoint inhibitor; immunotherapy; hepatocellular carcinoma; IMMUNE CHECKPOINT INHIBITORS; OPEN-LABEL; 2ND-LINE THERAPY; PHASE-III; CANCER; MULTICENTER; CHEMOTHERAPY; ANTIBODY; PEMBROLIZUMAB; COMBINATION;